Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions
- Hepatoblastoma
- Previously Treated Childhood Rhabdomyosarcoma
- Recurrent Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood Acute Myeloid Leukemia
- Recurrent Childhood Kidney Neoplasm
- Recurrent Childhood Malignant Germ Cell Tumor
- Recurrent Childhood Rhabdomyosarcoma
- Recurrent Childhood Soft Tissue Sarcoma
- Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
- Recurrent Neuroblastoma
- Recurrent Osteosarcoma
Interventions
- DRUG: Alisertib
- OTHER: Laboratory Biomarker Analysis
- OTHER: Pharmacological Study
Sponsor
Children's Oncology Group
Collaborators